v3.25.2
Revenue, Receivables, and Concentration of Credit Risk (Details) - Medicare Advantage Payors
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Revenue from Contract with Customer Benchmark | Payor A          
Concentration Risk [Line Items]          
Concentration risk, percentage 14.00% 22.00% 15.00% 22.00%  
Revenue from Contract with Customer Benchmark | Payor B          
Concentration Risk [Line Items]          
Concentration risk, percentage 14.00% 19.00% 15.00% 17.00%  
Revenue from Contract with Customer Benchmark | Payor C          
Concentration Risk [Line Items]          
Concentration risk, percentage 13.00%   12.00%    
Revenue from Contract with Customer Benchmark | Payor D          
Concentration Risk [Line Items]          
Concentration risk, percentage 10.00%        
Revenue from Contract with Customer Benchmark | Payor E          
Concentration Risk [Line Items]          
Concentration risk, percentage 12.00%   11.00%    
Receivables | Payor B          
Concentration Risk [Line Items]          
Concentration risk, percentage         11.00%
Receivables | Payor C          
Concentration Risk [Line Items]          
Concentration risk, percentage     11.00%   12.00%
Receivables | Payor D          
Concentration Risk [Line Items]          
Concentration risk, percentage     13.00%   13.00%
Receivables | Payor E          
Concentration Risk [Line Items]          
Concentration risk, percentage     14.00%   15.00%